| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/27/2014 | US20140056907 Anti-asic1 antibodies and uses thereof |
| 02/27/2014 | US20140056906 Secreted proteins |
| 02/27/2014 | US20140056905 Anti-kit antibodies and uses thereof |
| 02/27/2014 | US20140056904 Antibodies to TTR and Methods of Use |
| 02/27/2014 | US20140056903 Human antibodies to gfr alpha 3 and methods of use thereof |
| 02/27/2014 | US20140056902 Pharmaceutical agent comprising anti-bmp9 antibody as active ingredient for treatment of anemia such as renal anemia and cancer anemia |
| 02/27/2014 | US20140056901 Anti-tau antibodies and compositions for and methods of making and using in treatment, diagnosis and monitoring of tauopathies |
| 02/27/2014 | US20140056900 Method for inhibiting binding to b-cell receptor |
| 02/27/2014 | US20140056899 Anti-her antibodies |
| 02/27/2014 | US20140056897 Bispecific three-chain antibody-like molecules |
| 02/27/2014 | US20140056896 Anti-cd19 antibodies and uses in b cell disorders |
| 02/27/2014 | US20140056895 Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation |
| 02/27/2014 | US20140056892 VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders |
| 02/27/2014 | US20140056890 Binding Agents That Modulate the Hippo Pathway and Uses Thereof |
| 02/27/2014 | US20140056889 Compositions and method for treating autoimmune diseases |
| 02/27/2014 | US20140056887 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 02/27/2014 | US20140056886 Humanized Anti-IL-20 Antibody And Uses Thereof |
| 02/27/2014 | US20140056882 Treatment of pulmonary disease conditions |
| 02/27/2014 | US20140056879 Fc variants that extend antibody half-life |
| 02/27/2014 | US20140056878 Humanized antibodies directed against complement protein c5 |
| 02/27/2014 | US20140056877 Stabilized Liquid Anti-RSV Antibody Formulations |
| 02/27/2014 | US20140056872 Antagonists of neuropilin receptor function and use thereof |
| 02/27/2014 | US20140056871 Anti-inflammatory antibodies and uses therefor |
| 02/26/2014 | EP2700710A1 Anti-cyanobacteria recombinant antibody polypeptide, gene thereof, and preparation method thereof |
| 02/26/2014 | EP2700653A2 Complex in which anti-cotinine antibody is bound to conjugate of cotinine and binding substance, and use therefor |
| 02/26/2014 | EP2700652A1 Diagnosis and treatment of cancer using anti-itm2a antibody |
| 02/26/2014 | EP2700651A1 Compositions monovalent for CD28 binding and methods of use |
| 02/26/2014 | EP2700650A2 Monoclonal antibodies which specifically recognize human liver-carboxylesterase 1, hybridoma cell lines which produce monoclonal antibodies, and uses thereof |
| 02/26/2014 | EP2700410A1 Neutralizing monoclonal antibodies against the Nogo-66 receptor (NGR) and uses thereof |
| 02/26/2014 | EP2700036A2 Analyzing the expression of biomarkers in cells with clusters |
| 02/26/2014 | EP2699677A1 Protein for use as a medicament |
| 02/26/2014 | EP2699671A2 Anti-inflammatory agents |
| 02/26/2014 | EP2699603A1 Human monoclonal antibodies specific for glypican-3 and use thereof |
| 02/26/2014 | EP2699602A2 Monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies |
| 02/26/2014 | EP2699601A1 Antibody polypeptides that antagonize cd40 |
| 02/26/2014 | EP2699600A1 Method and constructs for the ph dependent passage of the blood-brain-barrier |
| 02/26/2014 | EP2699599A2 Gpr177 as target and marker in tumors |
| 02/26/2014 | EP2699598A2 Combinations of anti-4-1bb antibodies and adcc-inducing antibodies for the treatment of cancer |
| 02/26/2014 | EP2699597A1 Modified variable domain molecules and methods for producing and using them b |
| 02/26/2014 | EP2699596A2 Prostate-specific membrane antigen binding proteins and related compositions and methods |
| 02/26/2014 | EP2699587A1 Compositions relating to a mutant clostridium difficile toxin and methods thereof |
| 02/26/2014 | EP2699268A2 Novel binder-drug conjugates (adcs) and their use |
| 02/26/2014 | EP2699264A1 Antibodies and other molecules that bind b7-h1 and pd-1 |
| 02/26/2014 | EP2699262A2 Bispecific antibodies against her2 and cd3 |
| 02/26/2014 | EP2699260A1 Bispecifc antibodies against her2 |
| 02/26/2014 | EP2699259A1 Bcma-based stratification and therapy for multiple myeloma patients |
| 02/26/2014 | EP2699257A1 Peptide and conjugate vaccines for fungal infections |
| 02/26/2014 | EP2699248A1 Method for preparing a depleted plasma material consisting of one or more thrombogenic factors |
| 02/26/2014 | CN103608464A Clostridium difficile antigens |
| 02/26/2014 | CN103608358A Monoclonal antibody for acetylamantadine |
| 02/26/2014 | CN103608357A Hetero-dimeric immunoglobulins |
| 02/26/2014 | CN103608352A Method for producing protein preparation |
| 02/26/2014 | CN103608071A Formulation for anti-alpha4beta7 antibody |
| 02/26/2014 | CN103608040A Antibodies and other molecules that bind B7-H1 and PD-1 |
| 02/26/2014 | CN103608039A BCMA-based stratification and therapy for multiple myeloma patients |
| 02/26/2014 | CN103608038A Methods of administering beta7 integrin antagonists |
| 02/26/2014 | CN103602636A Anti-Orf virus B2L protein monoclonal antibody and application thereof |
| 02/26/2014 | CN103601807A Preparation method of monoclonal antibody with oxime carbamate pesticide butocarboxim resistant property |
| 02/26/2014 | CN103601806A Il-6结合分子 Il-6 binding molecules |
| 02/26/2014 | CN103601805A Light chain and heavy chain variable regions of human FGF21 monoclonal antibody |
| 02/26/2014 | CN103601804A Preparation method of endogenous retrovirus polyclonal antibody |
| 02/26/2014 | CN102993301B Vibrio cholerae flagellin monoclonal antibody and antigen capture ELISA kit |
| 02/26/2014 | CN102617731B Porcine circovirus-resistant type 2 egg yolk antibody, and preparation method and application thereof |
| 02/26/2014 | CN102282174B Antibodies against human epo receptor |
| 02/26/2014 | CN102093477B Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same |
| 02/26/2014 | CN101003573B Human antibodies that bind human tnfalpha |
| 02/25/2014 | US8658774 Meditopes and related meditope-monoclonal antibody delivery systems, synthesis and therapeutic uses thereof |
| 02/25/2014 | US8658771 Humanized antibodies against human interferon-alpha |
| 02/25/2014 | US8658770 Integrin alpha 8-beta 1-specific monoclonal antibody |
| 02/25/2014 | US8658769 Diagnostic marker for hepatocellular carcinoma comprising anti-FASN autoantibodies and a diagnostic composition for hepatocellular carcinoma comprising antigens thereof |
| 02/25/2014 | US8658766 Soluble hybrid Fcγ receptors and related methods |
| 02/25/2014 | US8658765 Non-natural MIC proteins |
| 02/25/2014 | US8658763 Amphiphilic peptides and hydrogel matrices thereof for bone repair |
| 02/25/2014 | US8658762 Polypeptides that inhibit dopamine D2 receptor-DISC1 interaction and methods of use thereof |
| 02/25/2014 | US8658386 Hybridomas producing highly specific monoclonal antibodies to detect mycobacterium avium subspecies paratuberculosis |
| 02/25/2014 | US8658385 Purinergic (P2X) receptors in extra-cellular body fluid |
| 02/25/2014 | US8658179 Glycosylated specificity exchangers |
| 02/25/2014 | US8658178 Carbon nanotube compositions and methods of use thereof |
| 02/25/2014 | US8658169 Antibodies against IL-25 |
| 02/25/2014 | US8658168 Compositions and methods for homoconjugates of antibodies which induce growth arrest of apoptosis of tumor cells |
| 02/25/2014 | US8658165 Method of treating aberrant mucus production in respiratory disease |
| 02/25/2014 | CA2629438C Human bnp immunospecific antibodies |
| 02/25/2014 | CA2544949C Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 02/25/2014 | CA2507936C Prion protein ligands and methods of use |
| 02/25/2014 | CA2505325C Stabilized single domain antibodies |
| 02/20/2014 | WO2014028865A1 Compositions and methods for detecting complement activation |
| 02/20/2014 | WO2014028777A2 Methods of treating a tauopathy |
| 02/20/2014 | WO2014028748A1 Interleukin 2 antibodies and antibody complexes |
| 02/20/2014 | WO2014028560A2 T-cell redirecting bispecific antibodies for treatment of disease |
| 02/20/2014 | WO2014028502A1 Engineered antibody-interferon fusion molecules for treatment of autoimmune diseases |
| 02/20/2014 | WO2014028446A1 Anti-jagged anitbodies and methods of use |
| 02/20/2014 | WO2014028374A1 Biomarkers predictive of rheumatoid arthritis or systemic lupus erythematosus response to anti-baff antibody therapy |
| 02/20/2014 | WO2014028354A1 Anti-pcsk9 antibodies with ph-dependent binding characteristics |
| 02/20/2014 | WO2014027959A1 Angiopoietin-like 4 antibody and a method of its use in cancer treatment |
| 02/20/2014 | WO2014027899A1 NT-proCNP AS A BIOMARKER OF VASCULAR DISORDERS AND PREGNANCY COMPLICATION |
| 02/20/2014 | WO2014027698A1 Anti-staphylococcus aureus capsular polysaccharide monoclonal antibody |
| 02/20/2014 | WO2014027697A1 Anti-pneumococcal surface protein (psp) monoclonal antibody |
| 02/20/2014 | WO2014027656A1 METHOD FOR INCREASING DEPOSITION OF COMPLEMENT C3b ON BACTERIAL CELL SURFACES AND PHAGOCYTIC ACTIVITY OF PHAGOCYTES, AND METHOD AND AGENT FOR TREATING BACTERIAL INFECTION |
| 02/20/2014 | WO2014027626A1 MONOCLONAL IgE ANTIBODY BONDING TO SWEAT ALLERGY ANTIGEN PROTEIN |
| 02/20/2014 | WO2014027363A1 A growth factor concentrate for treating hair loss |